E2F8 has been reported to overexpress in lung cancer, breast cancer, colorectal cancer, ovarian cancer, prostate cancer, esophageal squamous cell carcinoma and HCC [8,29–33]. This evidence concerns the gene E2F8 and esophageal squamous cell carcinoma.